The Berkeley Pharma Tech Journal of Medicine is a leading peer-reviewed journal that focuses on cutting-edge research in the field of neuroscience, gene and cell-based therapies, and personalized medicine. We are inviting researchers, scientists, clinicians, and scholars to submit their original manuscripts by September 15, 2023 for consideration for publication in our upcoming issue.Read more about Call for Papers
Ava Bagherian, the first author of the article titled Reversing Type 1 Diabetes: The Magnifying Potential of Stem Cell Encapsulation, 2022 (doi: https://doi.org/10.52243/bptjm.v1i2.27) has updated her contact information. For future inquiries, please contact the author at firstname.lastname@example.org, rather than the address listed on the article's front page.Read more about Contact Info Update for Bagherian et al., 2022 (Vol. 1 No. 2)
Read more to find out why we have chosen gene and cell-based therapies to be our focus for the second issue of our journal.Read more about The Theme of Our Second Issue: Advances in Gene and Gell Therapy
Berkeley Pharma Tech is hosting our fourth Bi-Annual Medical Research Conference on April 8, 2022 at 9AM-1PM PST. We are excited to introduce our keynote speaker, Dr. James Larrick, M.D., Ph.D. from Panorama Research Institute. Attendees can read his bio at https://www.pano.com/people.
The theme for the conference will be Gene and Cell Therapy. Attendees can attend multiple medical research presentations that capture their interest. Our conference will lead off at 9:00 AM PST with a Keynote Speech on the current advances in medicine.
Link for the Conference: Google meet
Please RSVP. Thank you, and looking forward to seeing you.